L1.7.5 Kilder

Kilder

Bauhofer A, Balaban Ü, Schimo S, Mayer M, Schüttrumpf J, Borte S. Adequate IVIG dosing is associated with an improved long-term outcome in secondary immunodeficiency: A prospective, non-interventional study. Int J Clin Pharmacol Ther. 2024. doi: 10.5414/CP204595 

El-Atawi K, De Luca D, Ramanathan R,Luna MS, Alsaedi S, Wahab MGA, Hamdi M, Saleh M. Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis. Cureus. 2023;15(12):e51375. 

Folkehelseinstituttet. Smittevernhåndboka [nettdokument]. Oslo: Folkehelseinstituttet [oppdatert 13.02.2023]. Tilgjengelig fra Smittevernhåndboka. 

Folkehelseinstituttet. Vaksinasjonshåndboka for helsepersonell [nettdokument]. Oslo: Folkehelseinstituttet [oppdatert 19.03.2024]. Tilgjengelig fra Vaksinasjonshåndboka for helsepersonell

Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM. Immunoglobulin treatment in primary antibody deficiency. Int J Antimicrob Agents. 2011;37(5):396-404. 

Mohamed MFH, Ward C, Beran A, Abdallah MA, Asemota J, Kelly CR. Efficacy, Safety, and Cost-effectiveness of Bezlotoxumab in Preventing Recurrent Clostridioides difficile Infection : Systematic Review and Meta-analysis. J Clin Gastroenterol. 2024;58(4):389-401. 

Ni SA, Brady MF. Botulism Antitoxin. 2023 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 30521228. 

Oslo universitetssykehus, Ullevål. Metodebok for infeksjonsmedisin. Oslo Universitetssykehus. 2024. 

Pati I, Cruciani M, Candura F,Massari MS, Piccinini V, Masiello F, Profili S, De Fulvio L, Pupella S, De Angelis V. Hyperimmune Globulins for the Management of Infectious Diseases. Viruses. 2023;15(7):1543. 

Rubinstein A, Mabudian M, McNeil D, Patel NC, Wasserman RL, Gupta S, Carrasco P, Chen J, Garcia E, Nagy A, Yel L. Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study. J Clin Immunol. 2024;44(8):181. 

Sil A, Basu S, Joshi V, Pilania RK, Siniah S, Suri D, Rawat A, Singh S. Immunoglobulin replacement therapies in inborn errors of immunity: a review. Front Pediatr. 2024;12:1368755.